Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

JUAN RAFAEL DE LA HABA RODRIGUEZ2026-01-292026-01-29202410.1007/s12094-024-03411-w2-s2.0-85189294400https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37647Cancer ResearchOncologyCancer ResearchOncologyHypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) studyresearch article